Net profit of Sun Pharmaceutical Industries rose 26.24% to Rs 2714.03 crore in the quarter ended March 2026 as against Rs 2149.88 crore during the previous quarter ended March 2025. Sales rose 13.61% to Rs 14559.75 crore in the quarter ended March 2026 as against Rs 12815.58 crore during the previous quarter ended March 2025.

For the full year,net profit rose 5.04% to Rs 11479.42 crore in the year ended March 2026 as against Rs 10929.04 crore during the previous year ended March 2025. Sales rose 11.87% to Rs 58220.11 crore in the year ended March 2026 as against Rs 52041.25 crore during the previous year ended March 2025.